OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of key gut microbial metabolites in the development and treatment of cancer
Kayla Jaye, Chun Guang Li, Dennis Chang, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Hourieh Sadrekarimi, Zhanna R. Gardanova, Morteza Bakhshesh, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78

β-glucans: a potential source for maintaining gut microbiota and the immune system
Ravindra Pal Singh, Aditi Bhardwaj
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 48

Sodium butyrate in both prevention and supportive treatment of colorectal cancer
Karolina Kaźmierczak-Siedlecka, Luigi Marano, Elvira Merola, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 40

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Yue Dong, Kexin Zhang, Jingge Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33

The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 25

The Emerging Role of the Microbiota in Breast Cancer Progression
Giancarla Bernardo, Valentino Le Noci, Martina Di Modica, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1945-1945
Open Access | Times Cited: 25

Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Thananya Jinato, Songtham Anuntakarun, Nantawat Satthawiwat, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 12

Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities
Sung Jin Kim, Myungchan Park, Ahnryul Choi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 112-112
Open Access | Times Cited: 8

Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
Rong Yang, Qian Li
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 34

Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy
Kayla Jaye, Dennis Chang, Chun Guang Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9490-9490
Open Access | Times Cited: 30

The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond
Radwa A. Eladwy, Hang Thi Vu, Ravi Shah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1716-1716
Open Access | Times Cited: 20

Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
Kunika, Norbert Frey, Ashraf Yusuf Rangrez
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7261-7261
Open Access | Times Cited: 16

Bacteriocins as Potential Therapeutic Approaches in the Treatment of Various Cancers: A Review of In Vitro Studies
Arnold Marshall Molujin, Sahar Abbasiliasi, Armania Nurdin, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4758-4758
Open Access | Times Cited: 27

Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?—“BiotaCancerSurvivors”: A Case-Control Study
T. Caleça, Pedro Ribeiro, M. Vitorino, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 594-594
Open Access | Times Cited: 15

Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
Ahmad K. Al-Khazaleh, Kayla Jaye, Dennis Chang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 872-872
Open Access | Times Cited: 5

Nondigestible oligosaccharides
Qixing Nie, Shanshan Zhang, Shaoping Nie
Elsevier eBooks (2025), pp. 17-37
Closed Access

Interactions between the tumor microbiota and breast cancer
Hua Guo
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access

Decoding the Link between Microbial Secondary Metabolites and Colorectal Cancer
Shengqin Wang, Mingjiang Wu
Computational Biology and Chemistry (2025) Vol. 115, pp. 108372-108372
Closed Access

Gut dysbiosis conveys psychological stress to activate LRP5/β-catenin pathway promoting cancer stemness
Cui Bai, Huandong Luo, Bin He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Bacterial metabolites: Effects on the development of breast cancer and therapeutic efficacy (Review)
Yan Guo, Wenyan Dong, Dezheng Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-9
Open Access

Insights into the gut microbiome-metabolite dynamics in breast cancer
Haseeb Manzoor, Masood ur Rehman Kayani
Gut Microbes Reports (2025) Vol. 2, Iss. 1, pp. 1-23
Open Access

Plantaricin BM-1 decreases viability of SW480 human colorectal cancer cells by inducing caspase-dependent apoptosis
He Wang, Junhua Jin, Xiao-Na Pang, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top